Half-life of Plasma Phytosterols in Preterm Infants on Parenteral Nutrition

Sponsor
Università Politecnica delle Marche (Other)
Overall Status
Completed
CT.gov ID
NCT02758834
Collaborator
(none)
45
27

Study Details

Study Description

Brief Summary

The purpose of this study is to determine plasma phytosterols half-lives in preterm infants who received intravenous soy oil-based lipid emulsions.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Several studies reported the relationship between plasma phytosterol concentrations and parenteral nutrition-associated cholestasis (PNAC). Information on plasma phytosterols half-lives in very-low-birth-weight (VLBW) preterm infants on lipid parenteral nutrition (PN) are lacking. In a prospective cohort study, plasma phytosterols (campesterol, stigmasterol and sitosterol) of VLBW preterm infants on routine PN will be measured by gas chromatography-mass spectrometry (GC-MS) during PN administration and after only lipid stopping. Plasma phytosterols half-lives will be calculated from the monoexponential decay curves. Blood samples will be weekly collected from 1st to 7th week of life during routine metabolic tolerance analysis or gas-analysis in order to avoid burden of additional phlebotomy. Samples will be collected in ethylenediaminetetraacetic acid-tubes and immediately centrifugated. Plasma will be stored in pyrogallol added-tubes at -20°C until analysis. Saponification reaction will be done using 5-alpha-cholestane as internal standard.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    45 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Half-life of Plasma Phytosterols in Very Low-birth-weight Preterm Infants on Routine Parenteral Nutrition With Soy-bean Oil Based Lipid Emulsions
    Study Start Date :
    Jan 1, 2014
    Actual Primary Completion Date :
    Apr 1, 2016
    Actual Study Completion Date :
    Apr 1, 2016

    Outcome Measures

    Primary Outcome Measures

    1. Change of plasma phytosterol concentrations in preterm infants during parenteral nutrition and after only lipid stopping. [7, 14, 21, 28, 35, 42 and 49 days]

      Plasma campesterol, stigmasterol and sitosterol concentrations will be measured at 7, 14, 21, 28, 35, 42 and 49 days from PN started. Plasma phytosterol concentrations will be measured by gas chromatography-mass spectrometry. Calibration curves will be used to calculate the phytosterol plasma concentrations (mg/L).

    Secondary Outcome Measures

    1. Normal liver function of preterm infants will be define by conjugated bilirubin values from blood samples under 1 mg/dl. [7 days and 42 days of life]

      Eligibility of preterm infants will be related to a normal liver function. Conjugated bilirubin value from blood sample is a good sign of hepatic function. The threshold value was defined to 1 mg/dl. Preterm infants who will have conjugated bilirubin values more of 1 mg/dl will be excluded from the study. The measure of conjugated bilirubin from blood samples will be routinely done at 7 and 42 days of life.

    2. Plasma phytosterols half-lives [After the collection of 3 or more blood samples collected when the lipid infusion is stopped.]

      Plasma phytosterol half-lives (days) will be measured using 3 or more plasma phytosterol concentrations calculated after only lipid stopping. Half-life of plasma phytosterols will be calculated from monoexponential decay curves.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    24 Weeks to 32 Weeks
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 24 weeks < gestational age < 32 weeks;

    • 500 g ≤ birth weight < 1250 g;

    • parenteral nutrition with soy oil-based lipid emulsions from the first hours of life;

    • parental consent.

    Exclusion Criteria:
    • length of parenteral nutrition > 24 days;

    • severe malformations;

    • inborn errors of metabolism;

    • severe congenital sepsis;

    • liver dysfunctions.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Università Politecnica delle Marche

    Investigators

    • Principal Investigator: Virgilio P. Carnielli, MD, PhD, Università Politecnica delle Marche

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Virgilio Paolo Carnielli, MD, Phd, Università Politecnica delle Marche
    ClinicalTrials.gov Identifier:
    NCT02758834
    Other Study ID Numbers:
    • DG-469
    First Posted:
    May 3, 2016
    Last Update Posted:
    May 3, 2016
    Last Verified:
    Apr 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by Virgilio Paolo Carnielli, MD, Phd, Università Politecnica delle Marche
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 3, 2016